Phio Pharmaceuticals
PHIO
11 hedge funds and large institutions have $591K invested in Phio Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 2 closing their positions.
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
57% more funds holding
Funds holding: 7 → 11 (+4)
0% less ownership
Funds ownership: 0% → 0% (-0%)
9% less capital invested
Capital invested by funds: $647K → $591K (-$56K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$170K |
| 2 |
VF
Virtu Financial
New York
|
+$89.7K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$38.1K |
| 4 |
SG Americas Securities
New York
|
+$24.7K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$11.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$520K |
| 2 |
EDRH
Edmond de Rothschild Holding
Chambesy,
Switzerland
|
-$4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CH
1
CVI Holdings
Wilmington,
Delaware
| $272K | +$170K | +76 | +292% |
|
|
VF
2
Virtu Financial
New York
| $107K | +$89.7K | +40 | New |
|
|
3
SG Americas Securities
New York
| $103K | +$24.7K | +11 | +39% |
|
|
4
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $45K | +$38.1K | +17 | New |
|
5
Citadel Advisors
Miami,
Florida
| $15K | +$6.73K | +3 | +100% |
|
|
TSS
6
Two Sigma Securities
New York
| $15K | +$11.2K | +5 | New |
|
7
Vanguard Group
Malvern,
Pennsylvania
| $12K | – | – | – |
|
8
UBS Group
Zurich,
Switzerland
| $11K | +$8.97K | +4 | New |
|
9
Renaissance Technologies
New York
| $5K | +$4.49K | +2 | New |
|
10
Morgan Stanley
New York
| $3K | – | – | – |
|
11
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $3K | +$2.24K | +1 | New |
|
|
KFS
12
Kelly Financial Services
Braintree,
Massachusetts
| $2 | – | – | – |
|
|
SM
13
Sabby Management
Miami Beach,
Florida
| – | -$520K | -265 | Closed |
|
|
EDRH
14
Edmond de Rothschild Holding
Chambesy,
Switzerland
| – | -$4K | -2 | Closed |
|
PHIO Hedge Fund Activity: Q1 2019 in Review
11 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Phio Pharmaceuticals (PHIO) for Q1 2019, worth a combined $591K — down 8.7% from $647K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new PHIO positions and 2 closed out — a net gain of 4 holders — while 3 added to existing stakes and 0 trimmed.
The largest buyer was CVI Holdings, adding an estimated $170K. The largest seller was Sabby Management, exiting entirely with an estimated $520K sold.
- 11 institutional investors held Phio Pharmaceuticals (PHIO) as of Q1 2019, up from 7 in Q4 2018.
- Funds reported $591K of Phio Pharmaceuticals stock for Q1 2019, down 8.7% quarter-over-quarter.
- 6 funds opened new Phio Pharmaceuticals positions in Q1 2019 and 2 closed out, a net change of +4 holders.
- The largest Phio Pharmaceuticals buyer in Q1 2019 was CVI Holdings, an estimated $170K added.
- The largest Phio Pharmaceuticals seller in Q1 2019 was Sabby Management, an estimated $520K sold.
Based on aggregated 13F filings for Q1 2019.